Retinitis Pigmentosa Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Oral N-acetylcysteine for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa Interventions: Drug: N-acetylcysteine; Drug: Placebo Sponsors: Johns Hopkins University; National Eye Institute (NEI); Duke University; Emory University; Massachusetts Eye and Ear Infirmary; Mayo Clinic; Medical College of Wisconsin; Retina Foundation of the Southwest; Stanford University; University of Calif ornia, Davis; University of Florida; University of Illinois at Chicago; University of Iowa; University of Miami; University of Michigan; University of Minnesota; University of Oklahoma;...
Source: ClinicalTrials.gov - September 13, 2022 Category: Research Source Type: clinical trials
The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa Interventions: Biological: Subtenon injection of Wharton jelly derived mesenchymal stem cells; Biological: Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes; Other: Placebo Sponsor: TC Erciyes University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2022 Category: Research Source Type: clinical trials
